User menu

Therapeutic monitoring of immunosuppressant drugs. Where are we?

Bibliographic reference Wallemacq, Pierre. Therapeutic monitoring of immunosuppressant drugs. Where are we?. In: Clinical chemistry and laboratory medicine : CCLM / FESCC, Vol. 42, no. 11, p. 1204-11 (2004)
Permanent URL http://hdl.handle.net/2078.1/10040
  1. Kahan Barry D., Keown Paul, Levy Gary A., Johnston Atholl, Therapeutic drug monitoring of immunosuppressant drugs in clinical practice, 10.1016/s0149-2918(02)85038-x
  2. Ihara Hideari, Shinkuma Denji, Ichikawa Yasuji, Nojima Michio, Nagano Shunsuke, Ikoma Fumihiko, INTRA- AND INTERINDIVIDUAL VARIATION IN THE PHARMACOKINETICS OF TACROLIMUS (FK506) IN KIDNEY TRANSPLANT RECIPIENTS?IMPORTANCE OF TROUGH LEVEL AS A PRACTICAL INDICATOR, 10.1111/j.1442-2042.1995.tb00444.x
  3. Kahan BD, Napoli KL, Kelly PA, Podbielski J, Hussein I, Urbauer DL, Katz SH, Van Buren CT, Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity, 10.1034/j.1399-0012.2000.140201.x
  4. Shaw Leslie M., Holt David W., Keown Paul, Venkataramanan Raman, Yatscoff Randall W., Current opinions on therapeutic drug monitoring of immunosuppressive drugs, 10.1016/s0149-2918(99)80044-7
  5. Siekierka John J., Hung Shirley H. Y., Poe Martin, Lin C. Shirley, Sigal Nolan H., A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin, 10.1038/341755a0
  6. Flanagan W. Michael, Corthésy Blaise, Bram Richard J., Crabtree Gerald R., Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A, 10.1038/352803a0
  7. Clipstone Neil A., Crabtree Gerald R., Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation, 10.1038/357695a0
  8. KOVARIK JOHN M., MUELLER EDGAR A., VAN BREE JOHANNES B., FLÜCKIGER SIMONE S., LANGE HARALD, SCHMIDT BERNHARD, BOESKEN WOLF H., LISON ARNO E., KUTZ KLAUS, CYCLOSPORINE PHARMACOKINETICS AND VARIABILITY FROM A MICROEMULSION FORMULATION—A MULTICENTER INVESTIGATION IN KIDNEY TRANSPLANT PATIENTS : , 10.1097/00007890-199409000-00004
  9. Floren Leslie C., Bekersky Ihor, Benet Leslie Z., Mekki Qais, Dressler Dawna, Lee Jean W., Roberts John P., Hebert Mary F., Tacrolimus oral bioavailability doubles with coadministration of ketoconazole*, 10.1016/s0009-9236(97)90150-8
  10. Venkataramanan, Transplant Proc, 23, 506 (1991)
  11. Gruber Scott A., Hewitt Jeanne M., Sorenson Amy L., Barber Donald L., Bowers Larry, Rynders Greg, Arrazola Luis, Matas Arthur J., Rosenberg Mark E., Canafax Daniel M., Pharmacokinetics of FK506 After Intravenous and Oral Administration in Patients Awaiting Renal Transplantation, 10.1002/j.1552-4604.1994.tb02052.x
  12. Jusko William J., Piekoszewski Wojciech, Klintmalm Goran B., Shaefer Mark S., Hebert Mary F., Piergies Antoni A., Lee Charles C., Schechter Paul, Mekki Qais A., Pharmacokinetics of tacrolimus in liver transplant patients*, 10.1016/0009-9236(95)90153-1
  13. Venkataramanan Raman, Swaminathan Arun, Prasad Tata, Jain Ashok, Zuckerman Sheila, Warty Vijay, McMichael John, Lever Jacqueline, Burckart Gilbert, Starzl Thomas, Clinical Pharmacokinetics of Tacrolimus : , 10.2165/00003088-199529060-00003
  14. Spencer Caroline M., Goa Karen L., Gillis Jane C., Tacrolimus : An Update of its Pharmacology and Clinical Efficacy in the Management of Organ Transplantation, 10.2165/00003495-199754060-00009
  15. Wallemacq P. E., Lhoëst G., Dumont P., Isolation, purification and structure elucidation of cyclosporin a metabolites in rabbit and man, 10.1002/bms.1200180107
  16. Christians U., Sewing K.-F., Cyclosporin metabolism in transplant patients, 10.1016/0163-7258(93)90059-m
  17. Sattler, Drug Metab Dispos, 20, 450 (1992)
  18. Gonschior A. -K., Christians U., Winkler M., Schiebel H. M., Linck A., Sewing K. -Fr., Simplified High-Performance Liquid Chromatography-Mass Spectrometry Assay for Measurement of Tacrolimus and Its Metabolites and Cross-Validation with Microparticle Enzyme Immunoassay : , 10.1097/00007691-199510000-00011
  19. Firdaous I., Vėrbeeck R. K., Hassoun A., Langrehr J. M., Wallemacq P. E., Excretion of tacrolimus glucuronides in human bile, 10.1007/bf03189810
  20. Iwasaki, Drug Metab Dispos, 23, 506 (1995)
  21. Laskow, Clin Transplant, 12, 489 (1998)
  22. Sokal Etienne Marc, Antunes Henedina, Beguin Claire, Bodeus Monique, Wallemacq Pierre, de Goyet Jean de Ville, Reding Raymond, Janssen Magda, Buts Jean Paul, Otte Jean Bernard, Early Signs And Risk Factors For The Increased Incidence Of Epstein-Barr Virus-Related Posttransplant Lymphoproliferative Diseases In Pediatric Liver Transplant Recipients Treated With Tacrolimus : , 10.1097/00007890-199711270-00011
  23. McDiarmid S. V., The Use of Tacrolimus in Pediatric Liver Transplantation : , 10.1097/00005176-199801000-00016
  24. SOLLINGER H. W., MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTS : , 10.1097/00007890-199508000-00003
  25. Allison AnthonyC., Eugui ElsieM., The design and development of an immunosuppressive drug, mycophenolate mofetil, 10.1007/bf00192309
  26. Shipkova Maria, Armstrong Victor William, Wieland Eberhard, Niedmann Paul Dieter, Schütz Ekkehard, Brenner-Weiß Gerald, Voihsel Martin, Braun Felix, Oellerich Michael, Identification of glucoside and carboxyl-linked glucuronide conjugates of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil, 10.1038/sj.bjp.0702399
  27. van Gelder T., Hilbrands L. B., Vanrenterghem Y., Weimar W., de Fijter J. W., Squifflet J. P., Hen?? R. J., Verpooten G. A., Navarro M. T., Hale M. D., Nicholls A. J., A RANDOMIZED DOUBLE-BLIND, MULTICENTER PLASMA CONCENTRATION CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ORAL MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION1 : , 10.1097/00007890-199907270-00018
  28. Dumont, J Immunol, 144, 506 (1990)
  29. Mahalati Kamran, Kahan Barry D., Clinical Pharmacokinetics of Sirolimus : , 10.2165/00003088-200140080-00002
  30. Johnston Atholl, Holt David W., Immunosuppressant drugs – the role of therapeutic drug monitoring, 10.1046/j.1365-2125.2001.00365.x
  31. Armstrong Victor W, Oellerich Michael, New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine, 10.1016/s0009-9120(00)00175-2
  32. Holt David W., Armstrong Victor W., Griesmacher Andrea, Morris Raymond G., Napoli Kimberly L., Shaw Leslie M., International Federation of Clinical Chemistry/International Association of Therapeutic Drug Monitoring and Clinical Toxicology Working Group on Immunosuppressive Drug Monitoring : , 10.1097/00007691-200202000-00011
  33. ATCHESON B, TAYLOR P, MUDGE D, JOHNSON D, PILLANS P, TETT S, Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection, 10.1016/j.jchromb.2003.10.033
  34. Streit F., Validation of a Rapid and Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method for Free and Total Mycophenolic Acid, 10.1373/clinchem.2003.024323
  35. Mandla Randeep, Line Pål-Dag, Midtvedt Karsten, Bergan Stein, Automated Determination of Free Mycophenolic Acid and Its Glucuronide in Plasma From Renal Allograft Recipients : , 10.1097/00007691-200306000-00025
  36. Napoli, Clin Chem, 42, 1943 (1996)
  37. Maleki Saber, Graves Scott, Becker Susan, Horwatt Ruth, Hicks David, Stroshane Ronald M., Kincaid Harvey, Therapeutic monitoring of sirolimus in human whole-blood samples by high-performance liquid chromatography, 10.1016/s0149-2918(00)89020-7
  38. Wallemacq Pierre E., Vanbinst Roger, Asta Stéphanie, Cooper Donald P., High-Throughput Liquid Chromatography-Tandem Mass Spectrometric Analysis of Sirolimus in Whole Blood, 10.1515/cclm.2003.140
  39. Kovarik J, Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: Pharmacokinetics, exposure-response relationships, and influence on cyclosporine, 10.1067/mcp.2001.112969
  40. Wallemacq P. E., Leeuw V. Van, Reding R., Goyet J., Sokal E. M., Otte J.-B., Clety S. Clement, Backer M. De, Clinical pharmacokinetics of Neoral in pediatric recipients of primary liver transplants, 10.1111/j.1432-2277.1997.tb00726.x
  41. David Olivier J., Johnston Atholl, Limited Sampling Strategies for Estimating Cyclosporin Area Under the Concentration–Time Curve: Review of Current Algorithms : , 10.1097/00007691-200104000-00003
  42. Levy Gary A., C2 Monitoring Strategy for Optimising Cyclosporin Immunosuppression from the Neoral??* Formulation : , 10.2165/00063030-200115050-00001
  43. Johnston A, David O.J, Cooney G.F, Pharmacokinetic validation of neoral absorption profiling, 10.1016/s0041-1345(00)00864-2
  44. Halloran Philip F., Helms Lisa M. H., Kung Lina, Noujaim Jean, THE TEMPORAL PROFILE OF CALCINEURIN INHIBITION BY CYCLOSPORINE IN VIVO1 : , 10.1097/00007890-199911150-00023
  45. Cole Edward, Midtvedt Karsten, Johnston Atholl, Pattison James, O???Grady Catherine, Recommendations for the Implementation of Neoral C2 Monitoring in Clinical Practice : , 10.1097/00007890-200205151-00004
  46. Morris Raymond G., Ilett Kenneth F., Tett Susan E., Ray John E., Fullinfaw Robert O., Cooke Russell, Cook Stephen, Cyclosporin Monitoring in Australasia: 2002 Update of Consensus Guidelines : , 10.1097/00007691-200212000-00001
  47. Mahalati, Ann Transplant, 5, 14 (2000)
  48. Oellerich Michael, Armstrong Victor W, Schütz Ekkehard, Shaw Leslie M, Therapeutic drug monitoring of cyclosporine and tacrolimus, 10.1016/s0009-9120(98)00049-6
  49. Macchi-Andanson Magali, Charpiat Bruno, Jelliffe Roger W., Ducerf Christian, Fourcade Nadine, Baulieux Jacques, Failure of Traditional Trough Levels to Predict Tacrolimus Concentrations : , 10.1097/00007691-200104000-00006
  50. Wong Kim Ming, Shek Chi Chung, Chau Ka Foon, Li Chun Sang, Abbreviated tacrolimus area-under-the-curve monitoring for renal transplant recipients, 10.1016/s0272-6386(00)70013-8
  51. Hale Michael D., Nicholls Andrew J., Bullingham Roy E.S., Hené Ronald, Hoitsma A., Squifflet Jean-Paul, Weimar W., Vanrenterghem Yves, Van de Woude Fokko J., Verpooten Gert A., The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation*, 10.1016/s0009-9236(98)90058-3
  52. Mourad, Clin Chem, 47, 88 (2001)
  53. Mourad, Clin Chem, 47, 1241 (2001)
  54. Mourad Michel, Wallemacq Pierre, K??nig Josiane, de Frahan Evelyne Henry, Eddour Djamila Chaib, De Meyer Martine, Malaise Jacques, Squifflet Jean Paul, Therapeutic Monitoring of Mycophenolate Mofetil in Organ Transplant Recipients : Is It Necessary?, 10.2165/00003088-200241050-00001
  55. Shaw Leslie M., Holt David W., Oellerich Michael, Meiser Bruno, van Gelder Teun, Current Issues in Therapeutic Drug Monitoring of Mycophenolic Acid: Report of a Roundtable Discussion : , 10.1097/00007691-200108000-00001
  56. Weber, J Am Soc Nephrol, 13, 759 (2002)
  57. Holt D.W, Denny K, Lee T.D, Johnston A, Therapeutic monitoring of sirolimus: its contribution to optimal prescription, 10.1016/s0041-1345(03)00214-8
  58. Kahan, Clin Transplant, 14, 97 (2000)
  59. McAlister Vivian C., Mahalati Kamran, Peltekian Kevork M., Fraser Albert, MacDonald Allan S., A Clinical Pharmacokinetic Study of Tacrolimus and Sirolimus Combination Immunosuppression Comparing Simultaneous to Separated Administration : , 10.1097/00007691-200206000-00004
  60. Thummel Kenneth E, A genetic test for immunosuppressant dose selection? : , 10.1097/00008571-200403000-00001
  61. Potter Julia M., Pharmacoeconomics of Therapeutic Drug Monitoring in Transplantation : , 10.1097/00007691-200002000-00007